WASHINGTON — To address a shortage of intravenous solution bags exacerbated by Hurricane Maria, the Food and Drug Administration has granted permission for a health supply company to import certain products to the United States from Australia and Ireland.
In letters dated Monday, the company, Baxter International, informed its customers that they could now order bags of saline solution that are manufactured abroad even though they are not FDA-approved because they are not marketed in the United States. Saline solution, given intravenously, is used for hydration and to dilute drugs.
For weeks, the FDA has been working with pharmaceutical companies to prevent drug shortages. Last week, Commissioner Scott Gottlieb said in a statement that there are about 40 drugs that the agency is “keeping a close watch on,” and that in particularly dire cases, the agency has helped companies acquire fuel, get finished drugs off the island, or has provided other logistical support.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect